Anti‐IL‐5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis

2005331 citationsJournal Article

Authors

J Oldhoff · University Medical Center Utrecht

Ulf Darsow · Technical University of Munich

Thomas Werfel · Medizinische Hochschule Hannover

K. Katzer · Technical University of Munich

A. Wulf · Medizinische Hochschule Hannover

J. Laifaoui · Technical University of Munich

DirkJan Hijnen

Abstract

Two single doses of 750 mg mepolizumab did not result in clinical success in patients with AD, despite a significant decrease in peripheral blood eosinophils.

Topics & Keywords

Asthma and respiratory diseases Dermatology and Skin Diseases Allergic Rhinitis and Sensitization

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Allergy

Volume 60, Issue 5, pp. 693-696

DOI: 10.1111/j.1398-9995.2005.00791.x

Field-Weighted Citation Impact: 4.27